Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,707 | -1,158 | -2,803 | -1,966 | -1,882 |
| Depreciation Amortization | 5 | 3 | 10 | 8 | 5 |
| Accounts receivable | 317 | -442 | -770 | -689 | -746 |
| Other Working Capital | 592 | 63 | 490 | 166 | -77 |
| Other Operating Activity | 997 | 1,438 | 1,245 | 1,007 | 1,014 |
| Operating Cash Flow | $203 | $-97 | $-1,827 | $-1,475 | $-1,685 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | -22 | -22 | -22 |
| Investing Cash Flow | $-1 | $N/A | $-22 | $-22 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 293 | 292 | 222 | 220 | 224 |
| Debt Repayment | -51 | -31 | -72 | -52 | -32 |
| Other Financing Activity | -26 | -14 | -60 | -41 | -28 |
| Financing Cash Flow | $217 | $247 | $91 | $127 | $163 |
| Exchange Rate Effect | 0 | 0 | 0 | 1 | 1 |
| Beginning Cash Position | 69 | 69 | 1,828 | 1,811 | 1,838 |
| End Cash Position | 488 | 220 | 70 | 443 | 295 |
| Net Cash Flow | $418 | $151 | $-1,758 | $-1,368 | $-1,543 |
| Free Cash Flow | |||||
| Operating Cash Flow | 203 | -97 | -1,827 | -1,475 | -1,685 |
| Capital Expenditure | -1 | N/A | -22 | -22 | -22 |
| Free Cash Flow | 202 | -97 | -1,849 | -1,496 | -1,707 |